Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation
Phase of Trial: Phase III
Latest Information Update: 24 Dec 2017
At a glance
- Drugs Apixaban (Primary) ; Warfarin
- Indications Cerebral haemorrhage; Intracranial haemorrhages; Stroke
- Focus Therapeutic Use
- Acronyms AREST
- 03 Nov 2017 Planned End Date changed from 1 Jan 2018 to 1 Dec 2018.
- 03 Nov 2017 Planned primary completion date changed from 1 Jan 2018 to 1 Dec 2018.
- 02 Oct 2015 Status changed from not yet recruiting to recruiting as per ClinicalTrials.gov record.